Taiichiro Kobayashi

Dr. Taiichiro Kobayashi

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
YMYasutaka Mizuno
Yasutaka Mizuno
YKYasuyuki Kato
Yasuyuki Kato
NTNozomi Takeshita
Nozomi Takeshita
MUMugen Ujiie
Mugen Ujiie
TKTaiichiro Kobayashi
Taiichiro Kobayashi
TTTomohiko Takasaki
Tomohiko Takasaki

23 November 2020 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
SNShohei Nakamura
Shohei Nakamura
YKYusuke Kanemasa
Yusuke Kanemasa
YAYuya Atsuta
Yuya Atsuta
SFSho Fujiwara
Sho Fujiwara
MTMasaru Tanaka
Masaru Tanaka
AIAkifumi Imamura
Akifumi Imamura

16 December 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TNTakeshi Nishijima
Takeshi Nishijima
KTKatsuji Teruya
Katsuji Teruya
SSSatoshi Shibata
Satoshi Shibata
YYYasuaki Yanagawa
Yasuaki Yanagawa
TKTaiichiro Kobayashi
Taiichiro Kobayashi
HGHiroyuki Gatanaga
Hiroyuki Gatanaga
The epidemiology of incident syphilis infection among HIV-1-infected men who have sex with men (MSM) largely remains unknown. The incidence and risk factors for incident syphilis (positive TPHA and RPR> = 1:8) among HIV-1-infected MSM who visited a large HIV clinic in Tokyo for the first time between 2008 and 2013 were determined, using clinical data and stored blood samples taken every three months for screening and determination of the date of incident syphilis. Poisson regression compared the incidence of syphilis at different observation periods. Of 885 HIV-1-infected MSM with baseline data, 34% either presented with active syphilis at baseline (21%) or became infected with syphilis during follow-up (13%). After excluding 214 patients (MSM with syphilis at baseline (n = 190) and no follow-up syphilis test (n = 24)), of 671 men, 112 (17%) developed incident syphilis with an incidence of 43.7/1,000 person-years [95% CI, 36.5–52.3]. The incidence decreased slightly during observation period although the trend was not significant (2008–2009: 48.2/1,000 person-years, 2010–2011: 51.1/1,000 person-years, 2012–2013: 42.6/1,000 person-years, 2014 to 2015: 37.9/1,000 person-years, p = 0.315). Multivariable analysis identified young age (40, HR 4.0, 95%CI 2.22–7.18, p<0.001), history of syphilis at baseline (HR 3.0, 95%CI 2.03–4.47, p<0.001), positive anti-amoeba antibody (HR 1.8, 95%CI 1.17–2.68, p = 0.006), and high baseline CD4 count (CD4 ≥350 /μL versus CD4 <200, HR 1.6, 95%CI 1.00–2.53, p = 0.050) as risk factors for incident syphilis. Incidence of syphilis was particularly high among young patients (age <33 years: 60.1/1,000 person-years). Interestingly, 37% of patients with incident syphilis were asymptomatic. Although incidence of syphilis did not increase during the observation period, it was high among HIV-1-infected MSM, especially among young HIV-1-infected MSM and those with history of syphilis, in Tokyo. Regular screening for syphilis needs to be strictly applied to this population.

1 June 2021 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
SFSho Fujiwara
Sho Fujiwara
MNMikio Nakajima
Mikio Nakajima
RKRichard H. Kaszynski
Richard H. Kaszynski
KFKazuaki Fukushima
Kazuaki Fukushima
MTMasaru Tanaka
Masaru Tanaka
AIAkifumi Imamura
Akifumi Imamura

1 March 2018 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
FNFukumi Nakamura-Uchiyama
Fukumi Nakamura-Uchiyama
YKYuichi Katanami
Yuichi Katanami
TKTadashi Kikuchi
Tadashi Kikuchi
STSaho Takaya
Saho Takaya
SKSatoshi Kutsuna
Satoshi Kutsuna
HMHaruhiko Maruyama
Haruhiko Maruyama

1 January 2017 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
TKTaiichiro Kobayashi
Taiichiro Kobayashi
KWKoji Watanabe
Koji Watanabe
HYHideaki Yano
Hideaki Yano
YMYukinori Murata
Yukinori Murata
TIToru Igari
Toru Igari
SOShinichi Oka
Shinichi Oka
Entamoeba histolytica is not a common causative agent of acute appendicitis. However, amoebic appendicitis can sometimes be severe and life threatening, mainly due to a lack of awareness. Also, its frequency, clinical features, and pathogenesis remain unclear. The study subjects were HIV-1-infected individuals who presented with acute appendicitis and later underwent appendectomy at our hospital between 1996 and 2014. Formalin-fixed paraffin-embedded preserved appendix specimens were reexamined by periodic acid-Schiff (PAS) staining and PCR to identify undiagnosed amoebic appendicitis. Appendectomies were performed in 57 patients with acute appendicitis. The seroprevalence of E. histolytica was 33% (14/43) from the available stored sera. Based on the medical records, only 3 cases were clinically diagnosed as amoebic appendicitis, including 2 diagnosed at the time of appendectomy and 1 case diagnosed by rereview of the appendix after the development of postoperative complications. Retrospective analyses using PAS staining and PCR identified 3 and 3 more cases, respectively. Thus, E. histolytica infection was confirmed in 9 cases (15.8%) in the present study. Apart from a significantly higher leukocyte count in E. histolytica -positive patients than in negative patients (median, 13,760 versus 10,385 cells/μl, respectively, P = 0.02), there were no other differences in the clinical features of the PCR-positive and -negative groups. In conclusion, E. histolytica infection was confirmed in 9 (15.8%) of the appendicitis cases. However, only 3, including one diagnosed after intestinal perforation, were diagnosed before the present analyses. These results strongly suggest there is frequently a failure to detect trophozoites in routine examination, resulting in an underestimation of the incidence of amoebic appendicitis.